Particularly, in GB, miR-7 was shown to act as a tumor suppressor miRNA, as it directly targets the epidermal growth factor receptor (EGFR) gene and negatively regulates the AKT signaling pathway through the direct inhibition of its upstream regulator, the insulin receptor substrate 2 (IRS2) [44]. The gene discussed is AKT1; the disease is neoplasm.